about
Role of microglia in central nervous system infectionsTranslocator protein (18 kDa): a promising therapeutic target and diagnostic tool for cardiovascular diseasesThe positron emission tomography ligand DAA1106 binds with high affinity to activated microglia in human neurological disordersImaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses in mouse models of Alzheimer's and other CNS pathologiesThe impact of high and low dose ionising radiation on the central nervous systemThe why and wherefore of hepatic encephalopathyGlial modulators: a novel pharmacological approach to altering the behavioral effects of abused substancesA systematic review of lessons learned from PET molecular imaging research in atypical parkinsonismTSPO-specific ligand vinpocetine exerts a neuroprotective effect by suppressing microglial inflammationMolecular Imaging Markers to Track Huntington’s Disease PathologyNeuroinflammatory imaging biomarkers: relevance to multiple sclerosis and its therapy.Synthesis and characterization of an MRI Gd-based probe designed to target the translocator protein.Microglia processes associate with diffusely injured axons following mild traumatic brain injury in the micro pig.Neuroimaging in Huntington's disease.Evaluation of 2-[¹⁸F]fluoroacetate kinetics in rodent models of cerebral hypoxia-ischemiaTranslocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative DiseasesMolecular Targets for PET Imaging of Activated Microglia: The Current Situation and Future Expectations.A graphical method to compare the in vivo binding potential of PET radioligands in the absence of a reference region: application to [¹¹C]PBR28 and [¹⁸F]PBR111 for TSPO imaging.Therapeutically targeting neuroinflammation and microglia after acute ischemic stroke.Evaluation of translocator protein quantification as a tool for characterising macrophage burden in human carotid atherosclerosis.Molecular imaging of microglia/macrophages in the brain.Development of N-methyl-(2-arylquinolin-4-yl)oxypropanamides as leads to PET radioligands for translocator protein (18 kDa).Molecular imaging of microglial activation in amyotrophic lateral sclerosis.Peripheral inflammatory markers in amnestic mild cognitive impairmentThe endotoxin-induced neuroinflammation model of Parkinson's disease.A comparison of the high-affinity peripheral benzodiazepine receptor ligands DAA1106 and (R)-PK11195 in rat models of neuroinflammation: implications for PET imaging of microglial activation.Neuroinflammation and J2 prostaglandins: linking impairment of the ubiquitin-proteasome pathway and mitochondria to neurodegeneration.Biomarkers for microglial activation in Alzheimer's disease.Magnitude of [(11)C]PK11195 binding is related to severity of motor deficits in a rabbit model of cerebral palsy induced by intrauterine endotoxin exposure.Evaluation of [(11)C]CB184 for imaging and quantification of TSPO overexpression in a rat model of herpes encephalitis.Radiation dosimetry and biodistribution of the TSPO ligand 11C-DPA-713 in humansCurrent pharmacological management of amyotrophic [corrected] lateral sclerosis and a role for rational polypharmacy.In vivo imaging of cerebral "peripheral benzodiazepine binding sites" in patients with hepatic encephalopathy.Radiosynthesis, In Vivo Biological Evaluation, and Imaging of Brain Lesions with [123I]-CLINME, a New SPECT Tracer for the Translocator ProteinTranslocator protein 18 kDa (TSPO): old dogma, new mice, new structure, and new questions for neuroprotection.The high affinity peripheral benzodiazepine receptor ligand DAA1106 binds specifically to microglia in a rat model of traumatic brain injury: implications for PET imaging.Solution structures of the prototypical 18 kDa translocator protein ligand, PK 11195, elucidated with 1H/13C NMR spectroscopy and quantum chemistry.Increased PK11195 PET binding in the cortex of patients with MS correlates with disabilityPriming the inflammatory pump of the CNS after traumatic brain injury.Thalamic inflammation after brain trauma is associated with thalamo-cortical white matter damage.
P2860
Q24563024-474AA270-74FB-400C-A423-DB965E181AC1Q24602947-F98A1CE8-ED30-4225-B976-DE3499DD658FQ24641816-C90E62C5-4468-4D5E-B70D-3B873FA012ECQ24642726-AC3D7E61-1DEC-4067-A9A6-596A3D3B59DFQ26740230-80A5D91D-4DB0-48EF-9ABC-FFDEE20F8D0FQ26771507-7CFC6FFA-3A3E-4029-9E84-B60A83FFE286Q27003932-B644134E-99FF-48EC-9F73-D20F170BE8BFQ28075227-FC46D8B1-ECAA-45E9-8EA8-309B0949A8F9Q28272695-EA3BECCC-CDCD-4B9A-A380-8B382F8C403AQ29248766-F9A100CE-518D-488B-A0E8-59FA5DA8EB40Q30576477-ACC9BFFE-E0E9-4111-A3DB-5015987A2936Q30585376-9E63B701-10FF-4DCB-A180-5044C1BE58CEQ30667015-098365ED-F19B-488F-BA77-E23CF786ABCCQ30834004-86EC376F-018B-4AA7-982A-30856D910F1CQ33581160-47B6A565-9B33-4AC9-A7B6-026646F8A2A6Q33624586-7486E9C7-C2F4-444B-9004-3821A0E9A2D1Q33624653-C6621013-6E1B-4465-8101-91CE59AF66A5Q33851465-AF1419CD-C7B0-4C76-9DB9-C37C2381C62EQ33893264-299EB108-1E0C-4F5C-A2EF-FF9186479B48Q33908068-D77BAF60-E80B-41B4-94EF-63DC577E76C8Q34276818-D60E7C74-B3DA-4F15-9E22-ACACA409715AQ34435657-A0E1A706-721B-424D-BE74-AB4F3F7148E6Q34541448-589136CD-7795-4BA7-AC51-5091D9F95B80Q34548819-364350DE-D25E-4D2A-8AB9-51C0CD9F4758Q34557246-950AE4E3-1FEA-48D6-83A3-D9ACDDE70BE3Q34635445-096B86F7-8AC4-4E24-BFA7-AC74EBF89C38Q34933261-A4512604-BA98-433F-AA6B-F7AC916AA2B0Q35504167-62097185-3512-4FD2-83F8-BD9B25F35B46Q35576378-F6196CEB-F439-4096-A2FB-9198B757E016Q35582898-17683E5D-A82D-42D4-AE7A-786897102A8BQ35743178-16026619-CA0A-4ADC-8604-15BC674056F2Q35753380-8135EB3C-73D8-4F93-AC65-879509A50868Q35760447-C3170E0C-3DE1-4997-9D75-063F588DAB17Q35833477-78EADD0A-E586-4AFD-93B7-2ADB3D1DB14FQ35837953-B62D0916-6590-43AA-A1BB-42D065280D36Q36094332-DCFA88EE-DF8E-40C3-A444-FC29947099A3Q36109447-0FA80196-5D98-40B3-8F86-D4764B25594AQ36146941-A3346F54-1B3A-4140-BE3F-D934A9E77C6DQ36198332-0CEA3FB3-F8C0-4458-87D4-2AE36F6AA087Q36337165-7563AA94-CEA5-46F3-BF32-F26890A97D89
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Visualising microglial activation in vivo.
@ast
Visualising microglial activation in vivo.
@en
type
label
Visualising microglial activation in vivo.
@ast
Visualising microglial activation in vivo.
@en
prefLabel
Visualising microglial activation in vivo.
@ast
Visualising microglial activation in vivo.
@en
P2860
P356
P1433
P1476
Visualising microglial activation in vivo.
@en
P2093
Richard B Banati
P2860
P304
P356
10.1002/GLIA.10144
P577
2002-11-01T00:00:00Z